|
KMID : 0379520070230020127
|
|
한국독성학회지
2007 Volume.23 No. 2 p.127 ~ p.133
|
|
|
Repression of {gamma}-Glutamylcysteine Synthetase and Glutathione S-Transferases by Metformin, an Anti-diabetic Agent, in H4IIE Rat Hepatocytes
|
|
Bae Eun-Ju
Cho Min-Joo
Kim Sang-Geon
|
|
|
Abstract
|
|
|
|
Metformin is a drug used to lower blood sugar levels in patients with type 2 diabetes via activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK). The primary objective of this study was to investigate whether metformin at the pharmacologically effective concentrations affects the expressions of {gamma}-glutamylcysteine synthetase and phase II antioxidant genes in the H4IIE cell. Treatment of the cells with either metformin or 5-aminoimidazole-4-carboxamide riboside (AICAR) abrogated tert-butylhydroxyquinone (t-BHQ) induction of {gamma}-glutamylcysteine synthetase, a rate limiting enzyme of GSH synthesis. The ability of t-BHQ to induce glutathione S-transferases (GSTs), a major class of phase II detoxifying enzymes that playa critical role in protecting cells from oxidative stress or electrophiles, was also inhibited by the agents. Transcriptional gene repression by metformin was verified by the GSTA2 promoter luciferase assay. Moreover, either metformin or AICAR treatment significantly decreased t-BHQ-dependent induction of other GSTs (i.e., GST{mu} and GST{pi} forms). Taken together, our data indicate that metformin treatment may result in the repression of {gamma}-glutamylcysteine synthetase and glutathione S-transferase genes possibly via AMPK activation.
|
|
|
KEYWORD
|
|
|
Metformin, AMPK, Oxidative stress, {gamma}GCS, GSTA2, GST{mu}, GST{pi}, Transcription
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|
|